Month: August 2020

CUPERTINO, CA, Aug. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Aemetis, Inc. (NASDAQ: AMTX) announced it received a letter from The NASDAQ Stock Market (“NASDAQ”) on August 11, 2020, which contained a NASDAQ compliance determination that the Company has regained compliance with NASDAQ Listing Rule 5450(b)(2)(C), which requires that listed securities maintain a minimum market value of publicly held shares of the Company’s common stock equal to or in excess of the $15,000,000 minimum.  On August 12, 2020, Aemetis received a letter from NASDAQ confirming compliance with NASDAQ Listing Rule 5450(a)(1), which requires that listed securities maintain a closing bid price equal to or in excess of $1.00 per share.The NASDAQ letters noted that the Company’s common stock has maintained a closing bid price of at least $1.00 per share...

Banken har på vegne af et bestyrelsesmedlem skulle foretage køb af Hvidbjerg Bank aktier. Ved en fejl er der indtastet stk. i stedet for beløb, hvilket har bevirket, at pågældende har fået 7.100 stk. aktier til en værdi af 418.421,50 kr. i stedet for som anmodet 223 stk. aktier.For yderligere detaljer henvises til det vedhæftede skema, hvori transaktioner udført af personer med ledelsesansvar og personer med nær tilknytning til disse skal indberettes og offentliggøres.Kontaktperson for denne meddelelse er bankdirektør Jens Odgaard på tlf. 96955220Vedhæftet filIndberetning af køb – Bilag

SHANGHAI, China, Aug. 18, 2020 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS), a leading developer and operator of high-performance data centers in China, today announced its unaudited financial results for the second quarter ended June 30, 2020.Second Quarter 2020 Financial HighlightsNet revenue increased by 36.2% year-over-year (“Y-o-Y”) to RMB1,342.2 million (US$190.0 million) in the second quarter of 2020 (2Q2019: RMB985.2 million).Service revenue increased by 35.5% Y-o-Y to RMB1,334.5 million (US$188.9 million) in the second quarter of 2020 (2Q2019: RMB985.1 million).Net loss was RMB101.0 million (US$14.3 million) in the second quarter of 2020, compared with a net loss of RMB93.2 million in the second quarter of 2019.   Adjusted EBITDA (non-GAAP) increased by 47.8% Y-o-Y to RMB633.4...

TORONTO, Aug. 18, 2020 (GLOBE NEWSWIRE) — Today, Freshii Inc. (TSX: FRII) (“Freshii”), the growing health and wellness brand and Flipp, a leader in retail technology, announced their partnership to offer Canadians value and savings content on the Flipp app. From now until September 10, Canadians can find great deals from Freshii on bowls for two, meals for three and plenty more!“We want to stay true to our commitment to making healthy food affordable and convenient, especially during these times,” said Estefania Bafunno, Director, Marketing at Freshii. “We continue to invest in digital marketing efforts and with Flipp’s target audience so aligned to Freshii’s, it was a natural fit to use this platform to offer value to our customers..”Flipp launched the Restaurant section on the app in 2020, offering Canadians great...

GREENWICH, Conn., Aug. 18, 2020 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of supply chain solutions, has been named a Top 100 Trucker by Inbound Logistics magazine for the 5th consecutive year. The 2020 Top 100 Truckers were selected from a broad range of transportation providers, including large truckload and less-than-truckload carriers, regional haulers and niche providers, such as last mile.Troy Cooper, president of XPO Logistics, said, “We’re honored that Inbound Logistics has once again recognized the value of our transportation services. We went into these challenging times with strong digital capabilities for freight management on our XPO Connect platform. Our ability to source capacity in atypical market environments is serving our customers well.”To determine the top truckers, Inbound...

MONTREAL, Aug. 18, 2020 (GLOBE NEWSWIRE) — (TSXV: GMN) GobiMin Inc. (“GobiMin” or the “Company”, together with its subsidiaries collectively the “Group”) reports its financial and operating results for the second quarter of 2020.  The unaudited condensed interim financial statements along with quarterly highlights of management’s discussion and analysis have been filed with SEDAR (www.sedar.com) and are also available at the website of the Company (www.gobimin.com). Financial HighlightsNote:(1) As non-IFRS measurements, EBITDA/(LBITDA) (earnings/(loss) before interest income and expense, income taxes, depreciation and amortization), EBITDA/(LBITDA) per share and Cash and cash equivalents per share do not comply with IFRS and, therefore, the amounts presented in the above table may not be comparable to similar data presented by other...

Tuebingen, Germany and Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) —First patient has been treated in Germany in Immatics’ ACTengine® IMA202-101 trialGerman regulatory agency, Paul-Ehrlich-Institute (PEI), granted approval to commence another clinical ACTengine® trial in Germany investigating Immatics’ IMA203 product candidateThree clinical trial sites in Germany have started recruiting patients for Immatics’ ACTengine® IMA200 trial seriesTuebingen, Germany and Houston, Texas, August 18, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies, announced today the treatment of the first patient in the IMA202-101 trial in Europe following the Clinical Trial Application (CTA, the equivalent of an IND approval by...

Tübingen, Deutschland und Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) —Der erste Patient in Deutschland wurde im Rahmen der Immatics‘ ACTengine® IMA202-101 Studie behandeltDie deutsche Zulassungsbehörde, das Paul-Ehrlich-Institut (PEI), hat den Antrag (CTA, Clinical Trial Application) für eine weitere klinische ACTengine®-Studie in Deutschland genehmigt. Die Studie wird Immatics‘ Produktkandidaten IMA203 untersuchenDrei klinische Studienzentren haben in Deutschland mit der Patienten-Rekrutierung für Immatics‘ ACTengine®-IMA200-Studienprogramme begonnen  Tübingen, Deutschland und Houston, Texas, 18. August 2020 – Immatics N.V. (NASDAQ: IMTX, „Immatics“), ein Unternehmen, das sich auf die Entwicklung und Herstellung von T-Zell-Immuntherapien für die Behandlung von Krebs fokussiert, gab heute die Behandlung des ersten Patienten im...

MIAMI, Aug. 18, 2020 (GLOBE NEWSWIRE) — Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that it has partnered with Alternative Research Associates, LLC and Larkin Hospital in Miami, FL to initiate a randomized, double-blinded, placebo-controlled phase I/II clinical trial against COVID-19 of its lead therapeutic candidate, which has been rebranded as Zofin.To date, a total of five patients have been treated with Zofin under the U.S. Food and Drug Administration’s (FDA) emergency Investigational New Drug (eIND) Program. Three of these COVID-19 patients were hospitalized in critical condition and, following treatment, regained complete recovery of lung and renal function. The other two patients were treated as outpatients...

SAN FRANCISCO, Aug. 18, 2020 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN) and Vivint Solar (NYSE: VSLR) today announced that Coatue US 24 LLC (“Coatue”), a vehicle affiliated with Coatue Management, L.L.C., has entered into a Stock Purchase Agreement with 313 Acquisition LLC (Blackstone affiliate) (“313 Acquisition”) for the purchase of 11,627,907 shares of Vivint Solar common stock in a private transaction. 313 Acquisition sold the shares to Coatue for $21.50 per Vivint Solar share, which was based on the trailing 10-day volume weighted average price of Vivint Solar common stock with a reference date of August 4, 2020, representing an aggregate purchase of approximately $250 million.In connection with the purchase, Coatue has (i) entered into a support agreement, pursuant to which Coatue agreed, among other things, to vote its shares...